Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2026

Feb 10, 2026

34129_dirs_2026-02-10_784666f7-988a-4d01-9207-90318c26ce1c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2026-02-07

Reporting Person: Risser Eric Blasius (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-07 Common Stock M 6668 Acquired 62657 Direct
2026-02-07 Common Stock F 2575 $1.81 Disposed 60082 Direct
2026-02-08 Common Stock M 11166 Acquired 71248 Direct
2026-02-08 Common Stock F 4311 $1.81 Disposed 66937 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-07 Restricted Stock Unit $ M 6668 Disposed Common Stock (6668) Direct
2026-02-08 Restricted Stock Unit $ M 11166 Disposed Common Stock (11166) Direct

Footnotes

F1: Restricted stock units convert into the Company's stock on a one-for-one basis.

F2: On February 7, 2025, the reporting person was granted 20,000 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

F3: On February 8, 2024, the reporting person was granted 33,500 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.